CompletedNot applicableNCT00559130

Efficacy Study of CytoSorb Hemoperfusion Device on IL-6 Removal in ARDS/ALI Patients With Sepsis

Studying Acute lung injury

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
MedaSorb Technologies, Inc
Principal Investigator
Martin K Kuhlmann, Prof. Dr.
Vivantes Klinikum
Intervention
CytoSorb Hemoperfusion(device)
Enrollment
100 enrolled
Eligibility
18-80 years · All sexes
Timeline
20072011

Study locations (6)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00559130 on ClinicalTrials.gov

Other trials for Acute lung injury

Additional recruiting or active studies for the same condition.

See all trials for Acute lung injury

← Back to all trials